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COMPARATIVE ANALYSIS OF VITAMIN D CONTENT IN POPULATION OF DIFFERENT  
CLIMATIC ZONES OF CARPATHIAN REGION 
V.V. Povorozniuk1, I.V. Pankiv2 
Abstract. The adequate vitamin D intake is found only in 19,5 % of inspected habitants of Carpathian region. The 
vitamin D deficiency is marked in 135 (80,5 %) and among them severe form is detected in 48 (28,4 %) of the inspected 
people. Frequency of vitamin D deficiency depends on a residence and increases with the height above a sea level. 25 (ОН) 
D level is higher among the ihabitants of low altitude region (27,14±1,26 nmol/l) comparatively with data of middle altitude 
region (21,37±1,34 nmol/l) and high altitude region (15,56±1,04 nmol/l). 
Key words: vitamin D, Carpathian region. 
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AGE-DEPENDENT PECULIARITIES OF ECHOCARDIOGRAPHIC  
PARAMETERS OF THE HEART IN PATIENTS WITH NONALCOHOLIC  
FATTY LIVER DISEASE  
Bukovinian State Medical University (Chernivtsi) 
Abstract. In present study echocardiographic features 
of the cardiovascular system in patients with nonalcoholic 
fatty liver disease (NAFLD) of different ages were exam-
ined. Structural and functional parameters of the heart 
change in nonalcoholic fatty liver patients with age: a pro-
gressive increase in the size of the left atrium, right ventri-
cle, and decrease of ejection fraction. In young patients the 
formation of concentric remodeling and eccentric hypertro-
phy, in elderly patients – development of its concentric 
hypertrophy was observed. The above-mentioned requires 
timely use of cardio-protective drugs in the treatment of 
these patients. 
Key words: nonalcoholic fatty liver disease, myocar-
dial remodeling, echocardiography. 
Introduction. Recently various researchers pay 
attention to the role of NAFLD in the development 
and progression of alterations in the cardiovascular 
system. Numerous epidemiological studies suggest 
an increased incidence of adverse cardiovascular 
events in patients with NAFLD as compared with the 
general population [2, 8, 11]. E. Ruttmann et al. stud-
ies for 12-year follow-up demonstrated a significant 
relationship between increased activity of gamma-
glutamyltransferase in NAFLD patients and cardio-
vascular mortality, even after adjustment of typical 
cardiovascular risk factors and normalization of body 
mass index [3]. S. Treeprasertsuketal showed that 
patients with NAFLD have a higher 10-year risk of 
coronary heart disease than an average person in 
general population of the same age and gender [10].  
Indicators of central hemodynamics in NAFLD 
patients are  characterized by increase of systolic and 
diastolic blood pressure, heart rate, total peripheral 
vascular resistance and cardiac output[4, 5]. In re-
sponse to hemodynamic changes structural changes 
in the left ventricle occur, including its hypertrophy, 
fibrosis of the stroma and dilatation of the heart cavi-
ties. The afore-mentioned facts are proved by in-
crease of the intra-ventricular septum, left ventricular 
posterior wall thickness and left ventricular myocar-
dial mass index [6]. 
The objective of our study was to examine 
echocardiographic features of the cardiovascular 
system in patients with NAFLD of different ages. 
Materials and methods. To find possible dif-
ferences in the functional and structural parameters 
of the heart echocardiographic study of 54 patients 
with NAFLD was conducted. All patients and 
healthy individuals were divided by age factor 
adopted by the European Regional Office of the 
WHO life periods classification (1963). According to 
this classification, three groups were determined: 15 
patients aged from 20 to 44 years (group I), 22 pa-
tients aged 45 - 59 years (group II) and 17 patients 
aged from 60 to 74 years (III group). Among the 
examined patients there were 29 males, and 25 fe-
males. The disease duration ranged from 1 to 5 
years. The control group consisted of 30 healthy in-
dividuals, which was divided according to the above-
mentioned classification into three subgroups – per 
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  10 people each. Before the examination, all patients 
and healthy volunteers gave written informed agree-
ment. 
Echocardiographic studies were performed us-
ing the ultrasound diagnostic system "En Visor 
HDS" firm Philips Ultrasound System (USA) with 
determination of structural and functional parameters 
by Asmi MN, Walsh MJ method [1]. Left ventricular 
myocardial mass (LVMM) was determined by 
R. Devereux and N. Reichek formula modified by 
the American Society of Echocardiography [7]. 
The left ventricular myocardial mass index 
(LVMMI) was calculated by the formula:   
 LVMMI (g/m²) = LVMM / BSA, 
where BSA is body surface area (m²). 
Left ventricular hypertrophy was diagnosed by 
the Guidelines for the management of Arterial Hy-
pertension (2007) [7]. According to this recommen-
dations left ventricular hypertrophy consider increas-
ing LVMMI for men > 125 g/m², for women > 110 
g/m². 
The relative left ventricle wall thickness (RWT) 
was calculated by the formula:  
RWT = (2 * ventricle posterior wall thickness in 
diastole) / EDV 
To evaluate the type of left ventricular remodel-
ing A. Ganau et al. classification was used [9]. 
Statistical analysis of the data was performed to 
determine the type of data distribution by comparing 
the arithmetic mean, mode and median and by means 
of Wilcoxon test. To determine statistical differences 
between two independent groups Mann-Whitney test 
was used, and between three or more independent 
groups – Kruskal-Wallis tests was used. 
Results. In patients with NAFLD increase in the 
sizes of the heart chambers, beginning from a young 
age was found. The left atrium diameter in patients of 
the 1st group prevailed to 14,0 % (p<0,01) as com-
pared with the corresponding control group. A similar 
pattern was observed in other age groups: in the 2nd 
group left atrium diameter was 9,9 % (p<0,05) and in 
the 3rdgroup – 6,7 % (p<0,05) higher as compared 
with those in the corresponding control groups. With 
age, the size of the left atrium in the observed pa-
tients also significantly increased (Table 1).  
In all age groups of patients with NAFLD a 
significant increase in the right ventricle size as com-
pared with the same in healthy volunteers was found: 
11,4 % (p<0,01) – in the young patients, 21,4 % 
(p<0,01) – in the mature patients and 17,2 % 
(p<0,01) – in the elderly patients. Reducing the dif-
ference in the elderly is associated primarily with an 
increase in size of the right ventricle in healthy indi-
viduals. Patients of the 2nd and 3rd groups were sig-
nificantly greater relative to similar parameters in the 
1st experimental group in 13,8 % (p<0,01) and 
12,5 % (p<0,01) respectively.  
End systolic left ventricle size in patients with 
NAFLD of all age groups was significantly higher as 
compared with practically healthy people. In particu-
lar, patients of the 1st experimental group showed an 
increase of this parameter in 9,3 % (p<0,01), of the 
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2nd experimental group – in 17,8 % (p<0,01), of the 
3rd experimental group – in 8,1 % (p<0,01). End dia-
stolic left ventricular size was significantly higher in 
the examined patients as compared with healthy vol-
unteers only in the adult patients, it prevailed 7,8 % 
(p<0,01) appropriate benchmarks (Table 1).  
Ejection fraction in the examined patients was 
reduced in all age groups. In the 1st, 2nd and 3rd 
groups examined ejection fraction was significantly 
lower (p<0,05) by 7,2 %, 7,9 % and 5,3 % as com-
pared with the corresponding control values (Table 
1).  
LVMM increased in patients with NAFLD as 
compared with healthy volunteers of appropriate age, 
and achieves maximal values in the elderly group. In 
patients of the 1st experimental group LVMM was 
16,7 % (p<0,01) higher comparing with the respec-
tive group of healthy people. Patients of the 2nd and 
3rd experimental groups showed the prevalence in 
this parameter on 29,2 % (p<0,01) and 27,0 % 
(p<0,01) respectively. LVMM in patients of the 2nd 
and 3rd groups was higher by 14,2 % (p<0,05) and 
20,1 % (p<0,01) respectively, as compared with the 
patients of the1st group (Table 1).  
A similar tendency was noted for LVMMI, 
which increased with age of the observed patients. In 
NAFLD patients of the 2nd group LVMMI was on 
13,4 % (p<0,01), while in the 3rd group of patients - 
already on 31,6 % (p <0,01) higher than in the pa-
tients of the 1st experimental group. It should be 
noted that an average LVMMI in adult and elderly 
patients were generally higher than standard rates 
[7]. LVMMI was the highest in elderly patients and 
pointed the rates of 159,45±10,23 g/m2. In healthy 
people LVMMI also increased with age, but this 
enlargement was slower and lower as compared with 
NAFLD patients (Table 1).  
Left ventricular geometry type was determined 
on the basis of LVMMI and relative thickness of left 
ventricle walls comparison. The normal geometric 
structure of the left ventricular myocardium was ob-
served in almost half of the patients in the first 
group. In 1/3 of the patients in this group eccentric 
hypertrophy was found, and in three patients – con-
centric hypertrophy. In the second experimental 
group patients with eccentric hypertrophy of the 
myocardium dominated, which accounted for 1/2 of 
the general quantity of the patients in this group. The 
number of patients with concentric remodeling and 
concentric hypertrophy accounted for about 1/5 of the 
total population of each. Only two patients in the 
second group showed normal geometric structure of 
the myocardium. In the third experimental group the 
number of patients with concentric hypertrophy of 
the myocardium significantly increased which ac-
counted for more than 2/3 of the total number of pa-
tients in this group. Three patients in this group were 
diagnosed to have concentric remodeling of the myo-
cardium, two – eccentric left ventricular hypertro-
phy. Persons with normal left ventricular geometry 
in the third experimental group were not found. 
Conclusions 
Structural and functional parameters of the heart 
change in nonalcoholic fatty liver patients with age: 
a progressive increase in the size of the left atrium, 
right ventricle, and decrease of ejection fraction. In 
young patients the formation of concentric remodel-
ing and eccentric hypertrophy, in elderly patients – 
development of its concentric hypertrophy was ob-
served. The above-mentioned requires timely use of 
cardio-protective drugs in the treatment of these pa-
tients. 
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ВОЗРАСТНЫЕ ОСОБЕННОСТИ ЭХОКАРДИОГРАФИЧЕСКИХ ПАРАМЕТРОВ СЕРДЦА У 
БОЛЬНЫХ С НЕАЛКОГОЛЬНОЙ ЖИРОВОЙ БОЛЕЗНЬЮ ПЕЧЕНИ  
В.П. Присяжнюк  
Резюме. Исследованы возрастные изменения эхокардиографических параметров у больных неалкогольной 
жировой болезнью печени. В обследованных пациентов с возрастом наблюдается изменение структурных и функ-
циональных параметров сердца: прогрессирующее увеличение размеров левого предсердия, правого желудочка, 
снижение фракции выброса. В них также изменяется геометрия миокарда левого желудочка, в молодом и зрелом 
возрасте проявляется формированием концентрического ремоделирования и эксцентрической гипертрофии, а у 
больных пожилого возраста – развитием его концентрической гипертрофии. Указанное требует своевременного 
применения кардиопротекторных средств в комплексном лечении этого контингента больных.  
Ключевые слова: неалкогольная жировая болезнь печени, ремоделирования миокарда, эхокардиография. 
ВІКОВІ ОСОБЛИВОСТІ ЕХОКАРДІОГРАФІЧНИХ ПАРАМЕТРІВ СЕРЦЯ У ХВОРИХ  
НА НЕАЛКОГОЛЬНУ ЖИРОВУ ХВОРОБУ ПЕЧІНКИ 
В.П. Присяжнюк 
Резюме. Досліджено вікові зміни ехокардіографічних параметрів у хворих на неалкогольну жирову хворобу 
печінки. В обстежених пацієнтів із віком спостерігається зміна структурних та функціональних параметрів серця: 
прогресуюче збільшення розмірів лівого передсердя, правого шлуночка, зниження фракції викиду. У них також 
змінюється геометрія міокарда лівого шлуночка, що в молодому та зрілому віці проявляється формуванням концен-
тричного ремоделювання та ексцентричної гіпертрофії, а у хворих літнього віку – розвитком його концентричної 
гіпертрофії. Зазначене вимагає своєчасного застосування кардіопротекторних засобів у комплексному лікуванні 
цього контингенту хворих. 
Ключові слова: неалкогольна жирова хвороба печінки, ремоделювання міокарда, ехокардіографія. 
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О.М. Радченко1, Н.С. Бек1, В.І. Потапов2 
ЛЕПТИНЕМІЯ ТА ПОКАЗНИКИ ВАРІАБЕЛЬНОСТІ РИТМУ СЕРЦЯ  
І ПРОГНОЗ У ХВОРИХ НА ГІПЕРТОНІЧНУ ХВОРОБУ З ОЖИРІННЯМ  
1 Львівський національний медичний університет імені Данила Галицького 
 2 Комунальна 8-ма міська клінічна лікарня, м. Львів 
Резюме. Обстеження 103 хворих на гіпертонічну 
хворобу з ожирінням виявило залежність від вмісту 
лептину (гіпер-, нормо- чи гіполептинемія) особливос-
тей автономної кардіорегуляції, електричної систоли 
шлуночків та прогнозу несприятливих кардіоваскуляр-
них подій. 
Ключові слова: лептин, гіпертонічна хвороба, 
варіабельність ритму серця. 
Вступ. Жирова тканина продукує адипокіни, 
до яких відноситься лептин (Л). Описано, що 
гіперлептинемія у пацієнтів за умов артеріальної 
гіпертензії (АГ) асоціюється зі збільшенням інде-
ксу маси тіла (ІМТ), окружності талії, систоліч-
ного (САТ) та діастолічного (ДАТ) артеріального 
тиску, інсуліну та інсулінорезистентністю [1]. У 
пацієнтів з низьким рівнем Л була дисліпідемія, 
вищі показники системного запалення та дисфун-
кції ендотелію [5]. Однак проблемі впливу адипо-
кінів на показники електричної стабільності міо-
карда присвячені лише окремі роботи. Виявлений 
зв'язок екстрасистолії з рівнями Л, ліпідів, марке-
рів запалення в осіб з діабетичною кардіоміопа-
тію з ожирінням (ОЖ) [2]. У жінок з ОЖ дослі-
дження варіабельності ритму серця (ВРС) встано-
вило обернені кореляції між низькочастотним 
компонентом спектра Low Frequency (LF) та Л, 
коефіцієнтом симпато-парасимпатичного балансу 
LF/High Frequency ( HF) та ДАТ, тоді як показни-
ки парасимпатичного впливу кореляцій не мали 
[9], показники ВРС були знижені та пов’язані з 
ренін-ангіотензиновою системою [4]. Однак віс-
церальна жирова маса обернено корелювала з 
показниками сумарної ВРС, а також високочасто-
тної і низькочастотної її складових [6]. Описано 
